Log In
Print this Print this

ActoBiotic for Type I diabetes

  Manage Alerts
Collapse Summary General Information
Company Intrexon Corp.
DescriptionActoBiotic delivering pro-insulin and IL-10
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat Type I diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today